A recent article has highlighted that by Tobramycin or the AMP, 6K-F17 could restore the effects of Orkambi on p.Phe508del-CFTR protein, suggesting a significant role of infection in the CF pathology (Laselva et al., 2020). The gene discussed is CFTR; the disease is cystic fibrosis.